Sign up now to receive our regular news briefs.

Israeli Start-Up Alcobra Develops New Treatment for Attention Deficit Disorder

December 2, 2013 3:26 pm 2 comments
Israel's Alcobra Pharmaceuticals has a new non-stimulant treatment for ADHD.

Israel's Alcobra Pharmaceuticals has a new non-stimulant treatment for ADHD.

Israeli pharmaceutical start-up Alcobra Pharmaceuticals is listed on the NASDAQ electronic stock exchange under the ticker ADHD, the disease it treats with a non-stimulant compound that is expected to come to the market in 2015.

In an interview with Israeli business daily Globes, CEO Dr. Yaron Daniely explained how the company was originally created in 2008 to develop the molecule metadoxine to help inhibit the effects of alcohol on the brain.

“The goal was to create a pill that would quickly reduce blood alcohol levels, so that people would be able to drive safely,” explains Daniely. “It turned out the drug had no significant impact on removing alcohol from the blood, but it had a very significant impact on cognitive ability. In driving, memory, and attention tests that were conducted, it was as though those people were not drunk, despite the fact that, in terms of the amount of alcohol in their blood, it was not clear that they would be able to stand on their own two feet. So the idea to treat Attention Deficit Disorder came about.”

A pilot the company conducted in 2010 among 40 adults with ADHD showed “an immediate and significant improvement in attention tests. As a result of this, the company reinvented itself,” Daniely said, which is when he was named by researchers Dr. Dalia Megiddo and Udi Gilboa to be its new CEO.

Bilingual with a Ph.D. from the Sackler Institute of Graduate Biomedical Sciences at the New York University School of Medicine, an NIH Visiting Fellow in Cell Biology, a Postdoctoral Fellow in the Department of Molecular Cell Biology at The Weizmann Institute for Science, in Rehovot, and an MBA from the Technion – Israel Institute of Technology, Daniely also was VP Business Development at Gamida Cell Ltd., managing its joint venture with Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA) to develop a cancer drug.

The idea was to approach TEVA to fund the start-up, which it did with $5 million to fund its first tests. But with TEVA later in a management crisis, and its options to increase its position in Alcobra expired, the team sought an IPO on the NASDAQ, which has since net it some $60 million in proceeds and a market capitalization of $220 million, more than enough to fund its final tests and market launch.

Daniely said the chemical compound metadoxine has been approved for 40 years for the treatment of liver disease in third-world countries, including India, China, Russia, and Thailand. The company has registered a patent for the use of metadoxine for neurological conditions, through a timed-release of the substance, so its effect on the patient lasts a few hours.

Globes said that Alcobra has no labs, its raw materials are manufactured by a third party in Germany, and the pills themselves are manufactured in the US. The company believes that the drug combines the benefits of the two existing classes of ADHD drugs – the stimulants, such as Ritalin and Concerta, and the non-stimulant drugs, such as Strattera – and claims that it does not have their drawbacks.

According to the company, the results of the clinical trials showed that the drug is not addictive, worked faster and was twice as effective as the existing non-stimulant drugs, and had a similar anti-ADHD effect to that of the stimulants. It primarily affects cognitive ability, less so hyperactivity.

Daniely advised other Israeli start-ups to follow four lessons from Alcobra’s successful IPO. “The first element was quality, and a refusal to compromise,” he said. “Alcobra, from day one, tried to be different from other companies. We have an almost pedantic stubbornness not to do things too small or too short, but rather to do the things the way we would if we were a company in Silicon Valley. Therefore, our Phase II trial didn’t include 20 people over two weeks, instead, it included 120 people, with a placebo control, over the course of six weeks, using the exact same measures that all the ADHD drugs in the world are measured by. Many companies understand too late that they are conducting poorer trials without the appropriate controls.”

The second element was the company’s target market. “There’s nothing like ADHD,” he says. “First of all, people understand the market; there are drugs, it is known how much each company is selling and why, there are patients, there is a market that turns over $4 billion each year in the US. Also, people think they understand what ADHD is. It affects almost everyone, their kid, or their nephew.”

A third element is the pace of development: “With ADHD, unlike rare cancers, participants for clinical trials are incredibly easy to find. So our time to market and our ability to build our development process are such that almost every month we have good news for shareholders. The phase III trial will include 300 patients, in 20 medical centers, over the course of six months.”

The fourth element that helped secure funding was his native-English speaking ability, personal CV and track record and a decision to invite well-known professionals from the ADHD research community to be on their team, in this case, Prof. Lenard Adler, a researcher from NYU and an expert in ADHD drug development, who serves as head of the clinical committee that advises the company. “When someone like him sits next to you and says: ‘I conducted the trial and I stand behind the results,’ they can’t blow you off. Israeli entrepreneurs need to understand this and bring these people to their companies, so they can bridge the gap,” Daniely said.

While the company tried to get funding in Israel, where ADHD is less frequently diagnosed, its success in raising money on the NASDAQ has led many other young pharma companies to its doors, seeking advice. Its success has also led to new projects.

“Many things happened at the company, and our ability to implement plans grew. We had a tremendous opportunity to treat fragile X syndrome, which is associated with autism. It is a very common condition, which is very difficult for many who suffer from it, and there is no treatment. In a trial we conducted on animals with a kind of fragile X, we came up with outstanding results. It completely normalized learning, memory, social behavior, and communication. In parallel, the market in the US was still on fire, and said, ‘go, secure the investment, and bring in more cash,'” Daniely said.

The funds Alcobra raised guarantee that the company will have full funding until it is approved as a drug for adult ADHD, which, according to Daniely, is expected to reach market in late 2015, and for children soon afterwards. The money will also fund the fragile X trial.

2 Comments

  • In this period of financial crisis, you usually do not have to spend huge amount of money just to find out girls
    get their clothes off in front individuals. You have to discover once the nude models from the sex chat website can be extremely beautiful and
    deliciously attractive. Military husbands stationed in the Middle
    East have been in a position to witness the birth of an youngster through webcams.

  • Davida Rosenberg

    Please update me when this will be available in the U.S.
    A family member age 36 male.. has suffered his whole young life with this condition.

Leave a Reply

Please note: comments may be published in the Algemeiner print edition. Comments written in all caps will be deleted.


Current day month ye@r *

More...

  • Arts and Culture Jewish Identity Jewish ‘Scandal’ Star Says He Remains True to Religious Ritual, Despite Scheduling, Dietary Conflicts

    Jewish ‘Scandal’ Star Says He Remains True to Religious Ritual, Despite Scheduling, Dietary Conflicts

    A star of the hit TV show Scandal told the community website Quora.com that, throughout his acting career, he has remained faithful to his Judaism, even when it has caused him to forfeit gigs. Joshua Malina, who plays the character of David Rosen on the ABC political-thriller series, reminisced about his early days in Hollywood, when he had no agent and could only go to open-call auditions. At one of these — a try-out for a commercial — he said he waited on a line that was “maybe a city […]

    Read more →
  • Arts and Culture Huffington Post Accused of ‘Jew-Hatred’ After Tweeting ‘Offensive’ Joke About Comedian at Video Music Awards

    Huffington Post Accused of ‘Jew-Hatred’ After Tweeting ‘Offensive’ Joke About Comedian at Video Music Awards

    The Huffington Post is facing backlash after joking about a Jewish comedian’s  appearance at the Video Music Awards (VMAs) on Sunday night. Josh “The Fat Jew” Ostrovsky took part in Nick Jonas’ performance of his song “Bacon,” staged in a New York diner — in a cameo role as a waiter throwing a handful of bacon in the air. Commenting on the show, the Huffington Post tweeted, “not thrilled at the fat jew [he] wasted all that perfectly good bacon!!!!!!” The message angered many Twitter users, who thought the joke […]

    Read more →
  • Sports Israeli Fans Mob, Dance With Basketball Player Amar’e Stoudemire at First Jerusalem Team Practice (VIDEO)

    Israeli Fans Mob, Dance With Basketball Player Amar’e Stoudemire at First Jerusalem Team Practice (VIDEO)

    Israeli basketball fans mobbed Hapoel Jerusalem’s newest player, American pro Amar’e Stoudemire, dancing around with him during a practice open to the public. On Friday, the team posted a video on Twitter of the happy romp with fans jumping around Stoudemire, while chanting in Hebrew. Unfamiliar with the lyrics, Stoudemire pumps his fist in the air. The basketball player, who has Jewish roots on his mother’s side, also waved a flag emblazoned with Hapoel Jerusalem’s logo. The former New York Knicks forward retired from the NBA earlier […]

    Read more →
  • Arts and Culture Playboy Columnist Calls Israel’s ‘Burning Man’ Festival ‘Ultimate Revenge on Hitler’

    Playboy Columnist Calls Israel’s ‘Burning Man’ Festival ‘Ultimate Revenge on Hitler’

    The Israeli version of the famed American Burning Man music festival is the “ultimate revenge on Hitler,” according to a column in Playboy magazine on Thursday. In his column, Jeff Weiss also took note of the fact that Midburn — a five-day bacchanal in the Negev Desert, self-described as an event celebrating “a communal life style, creativity, art and radical self-expression” — began on June 8, the day of the Sarona Market terrorist attack in Tel Aviv, which left four people dead. Weiss asked rhetorically, “What could needle the mustached […]

    Read more →
  • Arts and Culture Author of New Book on Connection Between Jews, Punk Rock Describes Bands Flinging Gefilte Fish, Bagels at Audience (INTERVIEW)

    Author of New Book on Connection Between Jews, Punk Rock Describes Bands Flinging Gefilte Fish, Bagels at Audience (INTERVIEW)

    Some punk rockers integrate their Jewish identity into their music through food, the author of a new book on the topic told The Algemeiner on Wednesday. Michael Croland, author of Oy Oy Oy Gevalt! Jews and Punk, described the way different musicians express this connection. “One band is known for throwing gefilte fish in the mosh pit, and people at its concert slide around on it while dancing,” he recounted. “Another used to drink Manischewitz [sweet kosher] wine out of a shofar [the ram […]

    Read more →
  • Sports Scottish Soccer Club Manager Hails ‘Fantastic’ Jewish-State Visit After Victory Over Israeli Team (VIDEO)

    Scottish Soccer Club Manager Hails ‘Fantastic’ Jewish-State Visit After Victory Over Israeli Team (VIDEO)

    The manager of Scotland’s Celtic soccer club lauded Israel, after his team won a match against the Jewish state’s Hapoel Be’er Sheva on Tuesday night. Brendan Rodgers said at a post-match press conference: On behalf of the players, the people of Celtic and Scotland, Israel’s been fantastic for us. We came out here on Sunday, [and from] the hotel, the staff, we’ve been very, very warmly received. The atmosphere at the game was amazing and, obviously, one team has to lose, but you have a wonderful team here, […]

    Read more →
  • Arts and Culture Second Jaffa Jazz Festival to Reunite International, Israeli Musicians

    Second Jaffa Jazz Festival to Reunite International, Israeli Musicians

    For the second time, Israel will host the Jaffa Jazz Festival, according to Broadwayworld.com. The festival will unite 43 Israeli musicians and eight international artists for a three-day event. The program will include a special performance by an ensemble of top jazz students studying at Belgium’s Royal Conservatoire of Antwerp, the Belgrade Music Academy in Serbia, Israel’s Rimon School of Music and the jazz program of the Israel Conservatory of Music in Tel Aviv. There will also be a jazz show for children led by Israeli saxophonist […]

    Read more →
  • Sports Israel’s First NASCAR Driver Revved Up to Win

    Israel’s First NASCAR Driver Revved Up to Win

    JNS.org – As a young boy growing up in Ashdod, Israel, Alon Day got his first go-kart at age 9. By 15, he was racing them. Less than a decade later, Day has become the first Israeli professional race car driver on the NASCAR circuit. He made history by competing in NASCAR’s Xfinity Series race at the Mid-Ohio Sports Car Course on August 13. “Driving a race car is not like any other sport,” Day told JNS.org. “You are actually almost flying […]

    Read more →